Aardvark Therapeutics
About:
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Website: https://aardvarktherapeutics.com
Top Investors: Cormorant Asset Management, LG Technology Ventures, Premier Partners, Surveyor Capital, Vickers Venture Partners
Description:
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017.
Total Funding Amount:
$129M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)aardvarktherapeutics.com
Founders:
Andreas Niethammer, Tien Lee
Number of Employees:
11-50
Last Funding Date:
2024-05-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai